Tff Pharmaceuticals Inc (TFFP) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket
 


Tff Pharmaceuticals Inc  (NASDAQ: TFFP)


Tff Pharmaceuticals Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tff Pharmaceuticals Inc's ROI in the third quarter of 2024?
Tff Pharmaceuticals Inc recorded a cumulative net loss of $-19 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -310.03%.

Within the Healthcare sector 825 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 3545 to 4158.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -63.64 % -50.8 % -49.94 % -46.07 % -41.72 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 6 5 10 14
Return On Investment (TTM) -310.03 % -224.75 % -194.51 % -162.47 % 241.72 %
TFFP's Overall Ranking # 4158 # 3545 # 0 # 4200 #
Seq. Investment Change TTM -30.74 % -15.81 % -21.64 % -20.42 % -6.28 %
Seq. Net Income Change TTM - - - - 34.28 %
Net Income (TTM) in Millions -19 -19 -20 -21 40




Return On Investment TFFP's Ranking
Within: No.
Industry # 396
Sector # 826
Overall # 4158

Return On Investment Statistics
High Average Low
-19.26 %
-115.07 %
-258.88 %
(Mar 31 2022)   (Sep 30 2024)







Financial Statements
Tff Pharmaceuticals Inc's III. Quarter Investments $ 3 Millions TFFP's Balance sheet
Tff Pharmaceuticals Inc's III. Quarter Income $ -4 Millions Quarterly TFFP's Income Statement
TFFP's Income by Division See TFFP's Income by Division


TFFP Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 10 23 39 74 56
Y / Y Investment Growth -58.39 % -40.73 % -47.28 % 30.41 % -
Net Income in Millions -21 -32 -31 -19 -12
Y / Y Net Income Growth - - - - -
Annual Return On Investment -222.05 % -138.19 % -80.02 % -25.24 % -21.04 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TFFP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TFFP's Competitors
Subscribers only: Roi for Tff Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for TFFP's Customers

Other Ratios
TFFP's Roa TFFP's Inventory Turnover Ratio TFFP's Growth Rates TFFP's Dividend Statistics
TFFP's Profitability Ratios TFFP's Asset Turnover Ratio TFFP's Dividend Growth
TFFP's Roe TFFP's Valuation Ratios TFFP's Financial Strength Ratios TFFP's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI


Date modified: 2026-09-26T07:40:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.